These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6893435)
1. Circadian plasma cortisol levels during topical use of desoximetasone and triamcinolone acetonide in man. Hartmann F; Proppe A; Proppe D Eur J Clin Pharmacol; 1980 May; 17(5):363-9. PubMed ID: 6893435 [TBL] [Abstract][Full Text] [Related]
2. Plasma cortisol levels in normal volunteers receiving either betamethasone valerate or desoximetasone by topical application. Bromley PA; Müller FO; Malan J; Torres J; Vanderbeke O S Afr Med J; 1978 Aug; 54(6):239-41. PubMed ID: 362568 [TBL] [Abstract][Full Text] [Related]
3. [Effect of the external use of triamcinolone acetonide under foil occlussive dressings on the plasma cortisol level and on the diurnal rhythm of plasma cortisol]. Hartmann F; Lahmann JJ Hautarzt; 1977 Apr; 28(4):198-202. PubMed ID: 559653 [TBL] [Abstract][Full Text] [Related]
5. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers. Wilson AM; Clark DJ; McFarlane L; Lipworth BJ Eur J Clin Pharmacol; 1997; 53(1):33-7. PubMed ID: 9349927 [TBL] [Abstract][Full Text] [Related]
6. [Radioimmunoassay of plasma cortisol and plasma cortisol circadian rhythm in external triamcinolone acetonide therapy]. Hartmann F; Schuster E Hautarzt; 1980 Aug; 31(8):433-6. PubMed ID: 7451149 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of triamcinolone acetonide and hydrocortisone in human plasma by high-performance liquid chromatography. Döppenschmitt SA; Scheidel B; Harrison F; Surmann JP J Chromatogr B Biomed Appl; 1996 Jun; 682(1):79-88. PubMed ID: 8832428 [TBL] [Abstract][Full Text] [Related]
8. Systemic absorption of topical steroids. Metabolic effects as an index of mild hypercortisolism. Garden JM; Freinkel RK Arch Dermatol; 1986 Sep; 122(9):1007-10. PubMed ID: 3527074 [TBL] [Abstract][Full Text] [Related]
9. Six-month controlled study of effect of desoximetasone and betamethasone 17-valerate on the pituitary-adrenal axis. Cornell RC; Stoughton RB Br J Dermatol; 1981 Jul; 105(1):91-5. PubMed ID: 7259982 [TBL] [Abstract][Full Text] [Related]
10. [Suppression of pituitary-adrenal axis by triamcinolone acetonide in asthmatics]. Li XH; Zhong NS Zhonghua Nei Ke Za Zhi; 1991 Sep; 30(9):542-5, 593. PubMed ID: 1666866 [TBL] [Abstract][Full Text] [Related]
12. [Treatment with topical corticosteroids in severe or resistant dermatoses]. Nolting S Derm Beruf Umwelt; 1985; 33(4):140-4. PubMed ID: 2931266 [TBL] [Abstract][Full Text] [Related]
13. Adrenocortical suppression by topically applied corticosteroids in healthy dogs. Zenoble RD; Kemppainen RJ J Am Vet Med Assoc; 1987 Sep; 191(6):685-8. PubMed ID: 2824410 [TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of desoximetasone in treatment of dermatoses and psoriasis. Nair BK; Nair CH Int J Dermatol; 1975 May; 14(4):277-9. PubMed ID: 1093984 [TBL] [Abstract][Full Text] [Related]
15. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis. Li JT; Goldstein MF; Gross GN; Noonan MJ; Weisberg S; Edwards L; Reed KD; Rogenes PR J Allergy Clin Immunol; 1999 Apr; 103(4):622-9. PubMed ID: 10200011 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous absorption of topically applied triamcinolone in children. Rasmussen JE Arch Dermatol; 1978 Aug; 114(8):1165-7. PubMed ID: 677913 [TBL] [Abstract][Full Text] [Related]